TMID enzymes as potential antiviral targets for the treatment of HHV infections Feb. 10, 2022 No Comments
New drug combinations with synergistic inhibitory activity against SARS-CoV-2 Feb. 9, 2022 No Comments
Xanadu signs agreements with Yale to support development of intranasal SARS-CoV-2 vaccine booster Feb. 9, 2022 No Comments
Immunome's antibody cocktail effective against live versions of SARS-CoV-2 Omicron variant in vitro Feb. 9, 2022 No Comments
MDL-001 significantly reduces SARS-CoV-2 viral load in lungs in preclinical study Feb. 9, 2022 No Comments
Discovery of novel monoclonal antibodies against emerging SARS-CoV-2 variants of concern Feb. 9, 2022 No Comments
Antibody DH-1047 shows protection against SARS-related strains and SARS-CoV-2 variants Feb. 8, 2022 No Comments